Mingfeng Qiu
Impact in
-
- Traditional Chinese Medicine Analysis
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 16
- Nanoparticle-Based Drug Delivery 16
-
- Advanced Drug Delivery Systems 5
Mingfeng Qiu
66 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 116
- Complementary and alternative medicine 252
- Biomaterials 307
- Pharmacology 176
- Pharmaceutical Science 116
- Molecular Biology 850
Countries citing papers authored by Mingfeng Qiu
This map shows the geographic impact of Mingfeng Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfeng Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfeng Qiu more than expected).
Fields of papers citing papers by Mingfeng Qiu
This network shows the impact of papers produced by Mingfeng Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfeng Qiu. The network helps show where Mingfeng Qiu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingfeng Qiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 12 | |
| 8 | 2024 | 6 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 52 | |
| 12 | 2017 | 6 | |
| 13 | 2016 | 18 | |
| 14 | 2016 | 110 | |
| 15 | 2016 | 4 | |
| 16 | 2014 | 17 | |
| 17 | 2014 | 48 | |
| 18 | Calcium antagonizing effect of Compound Danshen Sustained-release Tablet and comprehensive evaluation of sustained-release effect in vitro | 2005 | 1 |
| 19 | 2005 | 31 | |
| 20 | 2004 | 1 |
About Mingfeng Qiu
Mingfeng Qiu is a scholar working on Biomaterials, Pharmaceutical Science, Pharmacology, Complementary and alternative medicine and Biological Psychiatry, having authored 66 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (16 papers), Nanoplatforms for cancer theranostics (13 papers), Metabolomics and Mass Spectrometry Studies (10 papers), Erythrocyte Function and Pathophysiology (7 papers), RNA Interference and Gene Delivery (6 papers), Extracellular vesicles in disease (6 papers), Traditional Chinese Medicine Analysis (5 papers) and Advanced Drug Delivery Systems (5 papers). The work is most often cited by research in Complementary and alternative medicine (252 citations), Biomaterials (307 citations), Pharmacology (176 citations), Pharmaceutical Science (116 citations) and Molecular Biology (850 citations). Mingfeng Qiu has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Jing Su, Wei Jia, Faisal Raza, Zul Kamal, Guoxiang Xie, Aihua Zhao, Weien Yuan, Mingming Su, Zhaohui Xu and Yongyu Zhang. Their work appears in journals such as Pharmaceutics, Biomaterials Science, Journal of Proteome Research, Journal of Ethnopharmacology and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.